Correlation Between AlzeCure Pharma and Mendus AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AlzeCure Pharma and Mendus AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AlzeCure Pharma and Mendus AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AlzeCure Pharma and Mendus AB, you can compare the effects of market volatilities on AlzeCure Pharma and Mendus AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AlzeCure Pharma with a short position of Mendus AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of AlzeCure Pharma and Mendus AB.

Diversification Opportunities for AlzeCure Pharma and Mendus AB

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between AlzeCure and Mendus is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding AlzeCure Pharma and Mendus AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mendus AB and AlzeCure Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AlzeCure Pharma are associated (or correlated) with Mendus AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mendus AB has no effect on the direction of AlzeCure Pharma i.e., AlzeCure Pharma and Mendus AB go up and down completely randomly.

Pair Corralation between AlzeCure Pharma and Mendus AB

Assuming the 90 days trading horizon AlzeCure Pharma is expected to generate 2.66 times more return on investment than Mendus AB. However, AlzeCure Pharma is 2.66 times more volatile than Mendus AB. It trades about 0.22 of its potential returns per unit of risk. Mendus AB is currently generating about -0.09 per unit of risk. If you would invest  130.00  in AlzeCure Pharma on December 11, 2024 and sell it today you would earn a total of  132.00  from holding AlzeCure Pharma or generate 101.54% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

AlzeCure Pharma  vs.  Mendus AB

 Performance 
       Timeline  
AlzeCure Pharma 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in AlzeCure Pharma are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, AlzeCure Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.
Mendus AB 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Mendus AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

AlzeCure Pharma and Mendus AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AlzeCure Pharma and Mendus AB

The main advantage of trading using opposite AlzeCure Pharma and Mendus AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AlzeCure Pharma position performs unexpectedly, Mendus AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mendus AB will offset losses from the drop in Mendus AB's long position.
The idea behind AlzeCure Pharma and Mendus AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities